Spiro Medical raised $67M in a Series A round to support its neuromodulation technology.
- Amount
- $67M
- Stage
- Series A
- Announced
- 7 January 2026
- Leads
- Andera Partners, Omega Funds, Sherpa Healthcare Partners
- Other investors
- HSG, Supernova Invest, Northern Light Venture Capital, Hero Inc. Ltd UK
- Use of funds
- Develop its PNM system and execute clinical work required for regulatory approval in the United States.
- Checked
- Amount and date checked against the press source